Characterising neutrophil subtypes in cancer using human and murine single-cell RNA sequencing datasets

Neutrophils are a highly heterogenous cellular population. However, a thorough examination of the different transcriptional neutrophil states, between health and malignancy, has not been performed. We utilised single-cell RNA-sequencing of human and murine datasets, both publicly available and independently generated, to identify neutrophil transcriptomic subtypes and their developmental lineages in health and malignancy. Datasets of lung, breast and colorectal cancer (CRC) were integrated to establish and validate the reproducibility of neutrophil gene-signatures. Pseudo-time analysis was used to identify genes driving neutrophil development from health to cancer. Finally, ligand-receptor interactions and signalling pathways between neutrophils and other immune cell populations in primary CRC and metastatic CRC were investigated. We define two main neutrophil subtypes in primary tumours: an activated subtype sharing the transcriptomic signatures of healthy neutrophils; and a tumour-specific subtype. This signature is conserved in murine and human cancer, across different tumour types. In CRC metastases, neutrophils are more heterogenous, exhibiting additional transcriptomic subtypes. Pseudo-time analysis implicates an IL1B/CXCL8/CXCR2 axis in the progression of neutrophils from health to cancer and metastasis, with effects on T-cell effector function. Assessment of global communication signalling identified CD4+ T-cells and macrophages as dominant regulators of the immunosuppressive, metastatic niche, whereas CD8+ T-cells are receivers of signals from other immune cells. We propose that the emergence of metastatic-specific neutrophil subtypes is driven by an IL1/CXCL8/CXCR2 axis, with the evolution of different transcriptomic signals that impair T-cell function at the metastatic site. Thus, a better understanding of the neutrophil transcriptomic programming could optimise immunotherapeutic interventions into early and late interventions, targeting different neutrophil subtypes.

[1]  Allon M. Klein,et al.  A neutrophil response linked to tumor control in immunotherapy , 2023, Cell.

[2]  Nathan E. Reticker-Flynn,et al.  Neutrophil-activating therapy for the treatment of cancer. , 2023, Cancer cell.

[3]  N. Navin,et al.  Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer , 2022, Nature Cancer.

[4]  J. Poschmann,et al.  CLEC-1 is a death sensor that limits antigen cross-presentation by dendritic cells and represents a target for cancer immunotherapy , 2022, Science advances.

[5]  Y. Zhang,et al.  Mechanism and strategies of immunotherapy resistance in colorectal cancer , 2022, Frontiers in Immunology.

[6]  P. Tsantoulis,et al.  26P NOTCH1 driven metastasis in BRAF mutated colorectal cancer , 2022, Annals of Oncology.

[7]  G. Aust,et al.  To Detach, Migrate, Adhere, and Metastasize: CD97/ADGRE5 in Cancer , 2022, Cells.

[8]  Shiyu Zhang,et al.  CXCL8 in Tumor Biology and Its Implications for Clinical Translation , 2022, Frontiers in Molecular Biosciences.

[9]  Sangam Rajak,et al.  Multifaceted role of chemokines in solid tumors: from biology to therapy. , 2021, Seminars in cancer biology.

[10]  Qiu-lin Tang,et al.  Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer , 2021, Molecular Cancer.

[11]  L. Goulart,et al.  Annexin A1 as a Regulator of Immune Response in Cancer , 2021, Cells.

[12]  Ruibin Xi,et al.  Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level. , 2021, Cancer discovery.

[13]  C. Hedrick,et al.  Neutrophils in cancer: heterogeneous and multifaceted , 2021, Nature Reviews Immunology.

[14]  Daniel P Steinfort,et al.  Emerging and multifaceted role of neutrophils in lung cancer , 2021, Translational lung cancer research.

[15]  L. Carlin,et al.  Neutrophil dynamics in the tumor microenvironment. , 2021, The Journal of clinical investigation.

[16]  Jun Yao,et al.  Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy , 2021, Nature Communications.

[17]  S. Struyf,et al.  Studying Neutrophil Function in vitro: Cell Models and Environmental Factors , 2021, Journal of inflammation research.

[18]  M. Kopf,et al.  The thioredoxin‐1 inhibitor Txnip restrains effector T‐cell and germinal center B‐cell expansion , 2020, European journal of immunology.

[19]  S. Möller,et al.  An Attempt to Polarize Human Neutrophils Toward N1 and N2 Phenotypes in vitro , 2020, Frontiers in Immunology.

[20]  Deepali V. Sawant,et al.  Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer , 2020, Cell.

[21]  J. Utikal,et al.  Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies , 2019, Journal of Immunotherapy for Cancer.

[22]  J. McCorrison,et al.  Transcriptomics of type 2 diabetic and healthy human neutrophils , 2019, BMC Immunology.

[23]  D. Adams,et al.  Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis , 2019, Cancer cell.

[24]  C. Steele,et al.  Review: KRAS mutations are influential in driving hepatic metastases and predicting outcome in colorectal cancer. , 2019, Chinese clinical oncology.

[25]  Virginia Savova,et al.  Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species. , 2019, Immunity.

[26]  Y. Sakai,et al.  The Role of Tumor-Associated Neutrophils in Colorectal Cancer , 2019, International journal of molecular sciences.

[27]  Ambrose J. Carr,et al.  Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment , 2018, Cell.

[28]  Camille Stephan-Otto Attolini,et al.  TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis , 2018, Nature.

[29]  L. Levy,et al.  Tumor-associated neutrophils induce apoptosis of non-activated CD8 T-cells in a TNFα and NO-dependent mechanism, promoting a tumor-supportive environment , 2017, Oncoimmunology.

[30]  G. Bismuth,et al.  FAM65B controls the proliferation of transformed and primary T cells , 2016, Oncotarget.

[31]  M. Spinella,et al.  Serine/Threonine Kinase 17A Is a Novel p53 Target Gene and Modulator of Cisplatin Toxicity and Reactive Oxygen Species in Testicular Cancer Cells* , 2011, The Journal of Biological Chemistry.

[32]  C. Metz,et al.  Macrophage CD74 contributes to MIF-induced pulmonary inflammation , 2009, Respiratory research.

[33]  J. Whitton,et al.  Interferon-γ acts directly on CD8+ T cells to increase their abundance during virus infection , 2005, The Journal of experimental medicine.